Tobam Sells 4,088 Shares of Cardinal Health, Inc. $CAH

Tobam lessened its stake in Cardinal Health, Inc. (NYSE:CAH) by 45.8% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 4,845 shares of the company’s stock after selling 4,088 shares during the quarter. Tobam’s holdings in Cardinal Health were worth $814,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Wellington Management Group LLP raised its position in Cardinal Health by 1,666.7% during the first quarter. Wellington Management Group LLP now owns 2,384,192 shares of the company’s stock valued at $328,470,000 after purchasing an additional 2,249,241 shares in the last quarter. JPMorgan Chase & Co. lifted its position in shares of Cardinal Health by 40.0% during the 1st quarter. JPMorgan Chase & Co. now owns 4,175,992 shares of the company’s stock worth $575,327,000 after buying an additional 1,193,983 shares during the last quarter. Zurich Insurance Group Ltd FI boosted its stake in Cardinal Health by 4,935.9% in the first quarter. Zurich Insurance Group Ltd FI now owns 946,750 shares of the company’s stock valued at $130,434,000 after buying an additional 927,950 shares in the last quarter. Acadian Asset Management LLC grew its position in Cardinal Health by 92.5% in the second quarter. Acadian Asset Management LLC now owns 1,679,176 shares of the company’s stock valued at $282,063,000 after acquiring an additional 807,063 shares during the last quarter. Finally, Nuveen LLC acquired a new position in Cardinal Health during the first quarter worth about $106,065,000. Institutional investors own 87.17% of the company’s stock.

Insiders Place Their Bets

In other news, CEO Stephen M. Mason sold 41,575 shares of Cardinal Health stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total value of $6,187,191.50. Following the completion of the transaction, the chief executive officer directly owned 26,085 shares of the company’s stock, valued at approximately $3,881,969.70. This trade represents a 61.45% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Michelle D. Greene sold 13,500 shares of the company’s stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total value of $2,009,070.00. Following the sale, the insider owned 14,976 shares in the company, valued at approximately $2,228,728.32. The trade was a 47.41% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 271,676 shares of company stock valued at $40,489,525 over the last quarter. Company insiders own 0.12% of the company’s stock.

Cardinal Health Trading Down 0.3%

Shares of CAH stock opened at $204.77 on Wednesday. Cardinal Health, Inc. has a 1-year low of $114.60 and a 1-year high of $207.47. The stock has a market cap of $48.65 billion, a price-to-earnings ratio of 31.75, a PEG ratio of 1.39 and a beta of 0.72. The stock has a 50-day moving average of $162.25 and a 200-day moving average of $157.83.

Cardinal Health (NYSE:CAH) last announced its earnings results on Thursday, October 30th. The company reported $2.55 EPS for the quarter, beating the consensus estimate of $2.22 by $0.33. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The business had revenue of $64.01 billion for the quarter, compared to analysts’ expectations of $59.41 billion. During the same period in the prior year, the business posted $1.88 earnings per share. The firm’s revenue was up 22.4% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. Sell-side analysts forecast that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, January 15th. Investors of record on Friday, January 2nd will be paid a dividend of $0.5107 per share. This represents a $2.04 dividend on an annualized basis and a yield of 1.0%. The ex-dividend date of this dividend is Friday, January 2nd. Cardinal Health’s dividend payout ratio (DPR) is currently 30.77%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on CAH shares. Leerink Partners raised their price target on shares of Cardinal Health from $187.00 to $211.00 in a research note on Friday, October 31st. Evercore ISI increased their price objective on shares of Cardinal Health from $190.00 to $220.00 and gave the company an “outperform” rating in a research note on Friday, October 31st. Mizuho raised their target price on shares of Cardinal Health from $170.00 to $210.00 and gave the company an “outperform” rating in a research report on Monday, November 3rd. UBS Group upped their price target on shares of Cardinal Health from $185.00 to $220.00 and gave the stock a “buy” rating in a report on Friday, October 31st. Finally, Argus raised their price objective on Cardinal Health from $189.00 to $211.00 and gave the company a “buy” rating in a report on Tuesday, November 4th. Twelve research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat, Cardinal Health has an average rating of “Moderate Buy” and a consensus price target of $205.00.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.